查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485298

細胞計數市場規模- 按產品類型（儀器[血球計數器、自動細胞計數器、血液分析儀]、耗材和試劑）、應用（全血計數、基於細胞的療法、毒性）、最終用戶和預測，2024 年- 2032 年

Cell Counting Market Size - By Product Type (Instruments [Hemocytometers, Automated Cell Counters, Hematology Analyzers], Consumable & Reagents), Application (Complete Blood Count, Cell-based Therapies, Toxicity), End-user & Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在該領域技術和研究不斷進步的推動下，2024 年至 2032 年間，全球細胞計數市場規模的複合年成長率將超過 8.8%。隨著自動細胞計數、流式細胞儀和基於影像的細胞分析等不斷創新，研究人員配備了更準確、更有效率和高通量的細胞群定量方法。例如，2024 年 1 月，研究人員推出了一種先進的人工智慧 (AI) 工具，旨在透過分析細胞分裂來評估癌症分級。這項尖端技術被稱為 MitPro，可以準確計算有絲分裂數，這是各種癌症類型中癌症侵襲性的關鍵指標。

這些技術進步有助於簡化實驗室工作流程，同時能夠在藥物發現、癌症研究和再生醫學等各種應用中精確分析細胞活力、增殖和凋亡。此外，對個人化醫療和精準治療的日益關注進一步加大了對能夠提供精確可靠結果的複雜細胞計數技術的需求。因此，隨著細胞計數市場不斷滿足科學界不斷成長的需求，它有望顯著成長。

整個細胞計數產業根據產品類型、應用、最終用戶和地區進行分類。

儀器部分將在2024年至2032年期間經歷突破性的發展。從自動細胞計數器到流式細胞儀和基於影像的分析系統，市場提供了針對特定需求量身定做的各種儀器。隨著個人化醫療的興起和再生療法的進步，對精確細胞計數儀器的需求不斷升級，推動了細胞計數市場的創新和成長。

從2024 年到2032 年，基於細胞的治療領域的細胞計數市場佔有率將實現顯著的複合年成長率。劑量、品質控制和治療監測功效。隨著基於細胞的療法在解決包括癌症和退化性疾病在內的各種疾病方面獲得動力，對精確細胞計數技術的需求變得至關重要。這種需求推動了細胞計數市場的創新，推動了針對細胞療法的具體要求量身定做的先進儀器和方法的開發，從而促進了其成功實施和廣泛採用。

到 2032 年，歐洲細胞計數市場將累積可觀的估值。從學術研究到臨床診斷和藥物開發，精確的細胞計數至關重要。此外，該地區對個人化醫療和再生療法的重視進一步擴大了對精確細胞計數儀器和方法的需求。隨著歐洲在醫療進步方面繼續處於領先地位，在整個大陸醫療保健行業不斷變化的需求的推動下，細胞計數市場經歷了持續成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性疾病和血液疾病的發生率增加
      • 政府對意識和批准的支持不斷增加
      • 增加經費加速研發工作
      • 升級的細胞療法研究
      • 細胞計數技術不斷進步
    • 產業陷阱與挑戰
      • 計數技術的局限性
      • 先進細胞計數系統的高成本
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

  • 主要趨勢
  • 儀器
    • 血球計數器
    • 自動細胞計數器
      • 基於螢光影像的細胞計數器
      • 流式細胞儀
      • 犁刀計數器
    • 血液分析儀
      • 全自動分析儀
      • 半自動分析儀
    • 圖像細胞儀
    • 其他儀器
  • 耗材及試劑

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

  • 主要趨勢
  • 全血球計數
  • 基於細胞的療法
  • 生物加工
  • 毒性
  • 其他應用

第 7 章：市場估計與預測：按最終用戶分類，2018 年 - 2032 年

  • 主要趨勢
  • 醫院
  • 診斷實驗室
  • 研究機構
  • 製藥和生物技術公司
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biotek Instruments, Inc.
  • ChemoMetec A/S
  • DeNovix
  • Merck KGaA
  • NanoEnTek Inc
  • Olympus Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
簡介目錄
Product Code: 8496

Global Cell Counting Market Size will witness over 8.8% CAGR between 2024 and 2032, driven by continuous advancements in technology and research within the field. With ongoing innovations such as automated cell counting, flow cytometry, and image-based cell analysis, researchers are equipped with more accurate, efficient, and high-throughput methods for quantifying cellular populations. For instance, in January 2024, researchers unveiled an advanced artificial intelligence (AI) tool aimed at assessing cancer grading through the analysis of cell division. Known as MitPro, this cutting-edge technology accurately counts mitotic figures, which are crucial indicators of cancer aggressiveness, across various cancer types.

These technological advancements help streamline laboratory workflows while enabling precise analysis of cell viability, proliferation, and apoptosis across various applications, including drug discovery, cancer research, and regenerative medicine. Additionally, the growing focus on personalized medicine and precision therapeutics further amplifies the need for sophisticated cell counting technologies capable of delivering precise and reliable results. Consequently, the Cell Counting market is poised for significant growth as it continues to cater to the expanding demands of the scientific community.

The overall Cell Counting Industry is classified based on the product type, application, end-user, and region.

The instruments segment will undergo groundbreaking development from 2024 to 2032. These instruments play a critical role in quantifying cellular populations accurately and efficiently, facilitating various research and clinical applications. From automated cell counters to flow cytometers and image-based analysis systems, the market offers a diverse range of instruments tailored to specific needs. With the rise of personalized medicine and advancements in regenerative therapies, the demand for precise cell counting instruments continues to escalate, driving innovation and growth in the Cell Counting market.

The cell counting market share from the cell-based therapies segment will register a noteworthy CAGR from 2024 to 2032. These revolutionary treatments, ranging from stem cell therapies to immunotherapies, rely on accurate cell counting for dosage determination, quality control, and monitoring of treatment efficacy. As cell-based therapies gain momentum in addressing various diseases, including cancer and degenerative disorders, the need for precise cell counting technologies becomes paramount. This demand fuels innovation in the Cell Counting market, driving the development of advanced instruments and methodologies tailored to the specific requirements of cell-based therapies, thus facilitating their successful implementation and widespread adoption.

Europe cell counting market will amass a sizeable valuation by 2032. With a robust healthcare infrastructure and a focus on innovation, European researchers and clinicians increasingly rely on advanced cell counting technologies for various applications. From academic research to clinical diagnostics and pharmaceutical development, precise cell counting is essential. Moreover, the region's emphasis on personalized medicine and regenerative therapies further amplifies the demand for accurate cell counting instruments and methodologies. As Europe continues to lead in medical advancements, the Cell Counting market experiences sustained growth, driven by the evolving needs of the healthcare sector across the continent.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic disease and blood disorders
      • 3.2.1.2 Growing government support for awareness and approval
      • 3.2.1.3 Increasing fundings accelerated R&D efforts
      • 3.2.1.4 Escalated cell-therapy-based research
      • 3.2.1.5 Growing advancement in cell counting technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limitations of counting techniques
      • 3.2.2.2 High cost of advanced cell counting systems
  • 3.3 Regulatory landscape
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Instruments
    • 5.2.1 Hemocytometers
    • 5.2.2 Automated cell counters
      • 5.2.2.1 Fluorescence image-based cell counter
      • 5.2.2.2 Flow cytometer
      • 5.2.2.3 Coulter counter
    • 5.2.3 Hematology analyzers
      • 5.2.3.1 Fully-automated analyzers
      • 5.2.3.2 Semi-automated analyzers
    • 5.2.4 Image cytometry
    • 5.2.5 Other instruments
  • 5.3 Consumables & reagents

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Complete blood count
  • 6.3 Cell-based therapies
  • 6.4 Bioprocessing
  • 6.5 Toxicity
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic laboratories
  • 7.4 Research institutes
  • 7.5 Pharmaceutical & biotechnology companies
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Agilent Technologies, Inc.
  • 9.3 Beckman Coulter, Inc.
  • 9.4 Bio-Rad Laboratories, Inc.
  • 9.5 Biotek Instruments, Inc.
  • 9.6 ChemoMetec A/S
  • 9.7 DeNovix
  • 9.8 Merck KGaA
  • 9.9 NanoEnTek Inc
  • 9.10 Olympus Corporation
  • 9.11 Sysmex Corporation
  • 9.12 Thermo Fisher Scientific Inc.